BIOKRAFT INTERNATIONAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.2 SEK | +1.00% |
|
0.00% | -0.74% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 1,296 | 977.1 | 748.1 |
| Enterprise Value (EV) 1 | 1,753 | 1,483 | 1,114 |
| P/E ratio | -21 x | -25.2 x | -12.6 x |
| Yield | - | - | - |
| Capitalization / Revenue | 3.65 x | 2.36 x | 1.93 x |
| EV / Revenue | 4.93 x | 3.58 x | 2.88 x |
| EV / EBITDA | 52.2 x | 22.1 x | -248 x |
| EV / FCF | 590 x | -21.4 x | -5.01 x |
| FCF Yield | 0.17% | -4.68% | -19.9% |
| Price to Book | 2.48 x | 1.93 x | 1.44 x |
| Nbr of stocks (in thousands) | 29,872 | 30,534 | 30,534 |
| Reference price 2 | 43.40 | 32.00 | 24.50 |
| Announcement Date | 3/31/21 | 3/31/22 | 3/1/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 274.2 | 288.3 | 375.6 | 355.7 | 414.5 | 387.1 |
| EBITDA 1 | 19.3 | -9.26 | 58.62 | 33.6 | 67.03 | -4.496 |
| EBIT 1 | -30.1 | -71.88 | 3.586 | -11.21 | 10.26 | -66.22 |
| Operating Margin | -10.98% | -24.93% | 0.95% | -3.15% | 2.48% | -17.11% |
| Earnings before Tax (EBT) 1 | -77.68 | -117.1 | -63.16 | -64.47 | -45.49 | -95.37 |
| Net income 1 | -68.59 | -90.41 | -42.54 | -56.78 | -34.14 | -81.9 |
| Net margin | -25.01% | -31.36% | -11.33% | -15.96% | -8.24% | -21.16% |
| EPS 2 | -6.404 | -8.442 | -2.528 | -2.070 | -1.270 | -1.950 |
| Free Cash Flow 1 | -212.7 | -23.63 | -24.3 | 2.97 | -69.38 | -222.1 |
| FCF margin | -77.59% | -8.19% | -6.47% | 0.83% | -16.74% | -57.36% |
| FCF Conversion (EBITDA) | - | - | - | 8.84% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/27/18 | 4/25/19 | 6/4/20 | 3/31/21 | 3/31/22 | 3/1/23 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 704 | 785 | 758 | 456 | 506 | 366 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 36.48 x | -84.75 x | 12.93 x | 13.58 x | 7.542 x | -81.3 x |
| Free Cash Flow 1 | -213 | -23.6 | -24.3 | 2.97 | -69.4 | -222 |
| ROE (net income / shareholders' equity) | -33% | -60.9% | -31% | -16.8% | -7.58% | -13.9% |
| ROA (Net income/ Total Assets) | -1.72% | -3.75% | 0.18% | -0.49% | 0.4% | -2.35% |
| Assets 1 | 3,988 | 2,411 | -24,005 | 11,484 | -8,498 | 3,490 |
| Book Value Per Share 2 | 15.80 | 7.390 | 10.40 | 17.50 | 16.60 | 17.00 |
| Cash Flow per Share 2 | 8.110 | 8.850 | 8.110 | 12.40 | 14.80 | 12.90 |
| Capex 1 | 187 | 48.9 | 46.7 | 55.5 | 152 | 273 |
| Capex / Sales | 68.37% | 16.95% | 12.44% | 15.6% | 36.74% | 70.4% |
| Announcement Date | 2/27/18 | 4/25/19 | 6/4/20 | 3/31/21 | 3/31/22 | 3/1/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -0.74% | 80.29M | |
| -34.93% | 362M | |
| +43.50% | 166M | |
| -11.14% | 100M |
- Stock Market
- Equities
- BIOGAS Stock
- Financials Biokraft International AB
